These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 10407781)

  • 1. Recognition and management of fatty acid oxidation defects: a series of 107 patients.
    Saudubray JM; Martin D; de Lonlay P; Touati G; Poggi-Travert F; Bonnet D; Jouvet P; Boutron M; Slama A; Vianey-Saban C; Bonnefont JP; Rabier D; Kamoun P; Brivet M
    J Inherit Metab Dis; 1999 Jun; 22(4):488-502. PubMed ID: 10407781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of carnitine and fatty acid oxidation and its defects in infantile epilepsy.
    Tein I
    J Child Neurol; 2002 Dec; 17 Suppl 3():3S57-82; discussion 3S82-3. PubMed ID: 12597056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disorders of fatty acid oxidation.
    Tein I
    Handb Clin Neurol; 2013; 113():1675-88. PubMed ID: 23622388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disorders of mitochondrial long-chain fatty acid oxidation.
    Pollitt RJ
    J Inherit Metab Dis; 1995; 18(4):473-90. PubMed ID: 7494405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children.
    Bonnet D; Martin D; Pascale De Lonlay ; Villain E; Jouvet P; Rabier D; Brivet M; Saudubray JM
    Circulation; 1999 Nov; 100(22):2248-53. PubMed ID: 10577999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management and outcome in 75 individuals with long-chain fatty acid oxidation defects: results from a workshop.
    Spiekerkoetter U; Lindner M; Santer R; Grotzke M; Baumgartner MR; Boehles H; Das A; Haase C; Hennermann JB; Karall D; de Klerk H; Knerr I; Koch HG; Plecko B; Röschinger W; Schwab KO; Scheible D; Wijburg FA; Zschocke J; Mayatepek E; Wendel U
    J Inherit Metab Dis; 2009 Aug; 32(4):488-97. PubMed ID: 19399638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and biochemical monitoring of patients with fatty acid oxidation disorders.
    Lund AM; Skovby F; Vestergaard H; Christensen M; Christensen E
    J Inherit Metab Dis; 2010 Oct; 33(5):495-500. PubMed ID: 20066495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatty acid oxidation disorders: outcome and long-term prognosis.
    Wilcken B
    J Inherit Metab Dis; 2010 Oct; 33(5):501-6. PubMed ID: 20049534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of very long chain acyl-dehydrogenase deficiency from an infant's newborn screening card.
    Wood JC; Magera MJ; Rinaldo P; Seashore MR; Strauss AW; Friedman A
    Pediatrics; 2001 Jul; 108(1):E19. PubMed ID: 11433098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New genetic defects in mitochondrial fatty acid oxidation and carnitine deficiency.
    Stanley CA
    Adv Pediatr; 1987; 34():59-88. PubMed ID: 3318304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sudden and unexpected neonatal death: a protocol for the postmortem diagnosis of fatty acid oxidation disorders.
    Rinaldo P; Yoon HR; Yu C; Raymond K; Tiozzo C; Giordano G
    Semin Perinatol; 1999 Apr; 23(2):204-10. PubMed ID: 10331471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defects in mitochondrial fatty acid oxidation: clinical presentations and their role in sudden infant death.
    Pollitt RJ
    Padiatr Padol; 1993; 28(1):13-7. PubMed ID: 8446423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and biological features at diagnosis in mitochondrial fatty acid beta-oxidation defects: a French pediatric study of 187 patients.
    Baruteau J; Sachs P; Broué P; Brivet M; Abdoul H; Vianey-Saban C; Ogier de Baulny H
    J Inherit Metab Dis; 2013 Sep; 36(5):795-803. PubMed ID: 23053472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ESI-MS/MS study of acylcarnitine profiles in urine from patients with organic acidemias and fatty acid oxidation disorders.
    Kobayashi H; Hasegawa Y; Endo M; Purevsuren J; Yamaguchi S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Aug; 855(1):80-7. PubMed ID: 17301002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-chain fatty acid oxidation during early human development.
    Oey NA; den Boer ME; Wijburg FA; Vekemans M; Augé J; Steiner C; Wanders RJ; Waterham HR; Ruiter JP; Attié-Bitach T
    Pediatr Res; 2005 Jun; 57(6):755-9. PubMed ID: 15845636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Medium-chain acyl-CoA-dehydrogenase (MCAD) deficiency: French consensus for neonatal screening, diagnosis, and management].
    Feillet F; Ogier H; Cheillan D; Aquaviva C; Labarthe F; Baruteau J; Chabrol B; de Lonlay P; Valayanopoulos V; Garnotel R; Dobbelaere D; Briand G; Jeannesson E; Vassault A; Vianey-Saban C;
    Arch Pediatr; 2012 Feb; 19(2):184-93. PubMed ID: 22244319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical protocols concerned with disorders of fatty acid beta oxidation].
    Kania M
    Przegl Lek; 1994; 51(1):25-8. PubMed ID: 8208992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and genetic characteristics of patients with fatty acid oxidation disorders identified by newborn screening.
    Kang E; Kim YM; Kang M; Heo SH; Kim GH; Choi IH; Choi JH; Yoo HW; Lee BH
    BMC Pediatr; 2018 Mar; 18(1):103. PubMed ID: 29519241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial fatty acid oxidation disorders in Thai infants: a report of 3 cases.
    Wasant P; Matsumoto I; Naylor E; Liammongkolkul S
    J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S710-9. PubMed ID: 12403251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New developments in the pathophysiology, clinical spectrum, and diagnosis of disorders of fatty acid oxidation.
    Treem WR
    Curr Opin Pediatr; 2000 Oct; 12(5):463-8. PubMed ID: 11021412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.